Halloran K, Stenhouse C, Wu G, Bazer F
Adv Exp Med Biol. 2021; 1332:85-105.
PMID: 34251640
DOI: 10.1007/978-3-030-74180-8_6.
Ries C
Cell Mol Life Sci. 2013; 71(4):659-72.
PMID: 23982756
PMC: 11113289.
DOI: 10.1007/s00018-013-1457-3.
Givvimani S, Munjal C, Tyagi N, Sen U, Metreveli N, Tyagi S
PLoS One. 2012; 7(3):e32388.
PMID: 22479323
PMC: 3313999.
DOI: 10.1371/journal.pone.0032388.
Camacho-Vanegas O, Camacho S, Till J, Miranda-Lorenzo I, Terzo E, Ramirez M
Am J Hum Genet. 2012; 90(4):614-27.
PMID: 22464254
PMC: 3322221.
DOI: 10.1016/j.ajhg.2012.02.024.
Givvimani S, Munjal C, Gargoum R, Sen U, Tyagi N, Vacek J
J Appl Physiol (1985). 2011; 110(4):1093-100.
PMID: 21233344
PMC: 3075122.
DOI: 10.1152/japplphysiol.01064.2010.
The novel polyamine analogue CGC-11093 enhances the antimyeloma activity of bortezomib.
Carew J, Nawrocki S, Reddy V, Bush D, Rehg J, Goodwin A
Cancer Res. 2008; 68(12):4783-90.
PMID: 18559525
PMC: 2749595.
DOI: 10.1158/0008-5472.CAN-07-6483.
The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2.
Stetler-Stevenson W
Cancer Metastasis Rev. 2007; 27(1):57-66.
PMID: 18058195
PMC: 2254553.
DOI: 10.1007/s10555-007-9105-8.
Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.
Guedez L, McMarlin A, Kingma D, Bennett T, Stetler-Stevenson M, Stetler-Stevenson W
Am J Pathol. 2001; 158(4):1207-15.
PMID: 11290537
PMC: 1891911.
DOI: 10.1016/S0002-9440(10)64070-9.
Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms.
Jaalinoja J, Herva R, Korpela M, Hoyhtya M, Turpeenniemi-Hujanen T
J Neurooncol. 2000; 46(1):81-90.
PMID: 10896208
DOI: 10.1023/a:1006421112839.
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.
Cox G, Steward W, OByrne K
Thorax. 1999; 54(2):169-79.
PMID: 10325924
PMC: 1745414.
DOI: 10.1136/thx.54.2.169.
Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer.
Gohji K, Fujimoto N, Ohkawa J, Fujii A, Nakajima M
Br J Cancer. 1998; 77(4):650-5.
PMID: 9484825
PMC: 2149919.
DOI: 10.1038/bjc.1998.104.
Selection of a histidine-containing inhibitor of gelatinases through deconvolution of combinatorial tetrapeptide libraries.
Ferry G, Boutin J, Atassi G, Fauchere J, Tucker G
Mol Divers. 1997; 2(3):135-46.
PMID: 9238644
DOI: 10.1007/BF01682201.
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Volpert O, Ward W, Lingen M, Chesler L, Solt D, Johnson M
J Clin Invest. 1996; 98(3):671-9.
PMID: 8698858
PMC: 507476.
DOI: 10.1172/JCI118838.
The use of angiostatic steroids to inhibit cartilage destruction in an in vivo model of granuloma-mediated cartilage degradation.
Colville-Nash P, El-Ghazaly M, Willoughby D
Agents Actions. 1993; 38(1-2):126-34.
PMID: 8480533
DOI: 10.1007/BF02027224.
Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme.
Fridman R, Bird R, Hoyhtya M, Oelkuct M, Komarek D, Liang C
Biochem J. 1993; 289 ( Pt 2):411-6.
PMID: 8380993
PMC: 1132182.
DOI: 10.1042/bj2890411.
92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.
Inoue M, Guidice G, Parks W
J Clin Invest. 1994; 93(5):2022-30.
PMID: 8182134
PMC: 294314.
DOI: 10.1172/JCI117196.
Cellular markers that distinguish the phases of hemangioma during infancy and childhood.
Takahashi K, Mulliken J, Kozakewich H, Rogers R, Folkman J, Ezekowitz R
J Clin Invest. 1994; 93(6):2357-64.
PMID: 7911127
PMC: 294441.
DOI: 10.1172/JCI117241.
Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas.
Lindsay C, Thorgeirsson U
Clin Exp Metastasis. 1995; 13(5):381-8.
PMID: 7641422
DOI: 10.1007/BF00121914.
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.
Angiolillo A, Sgadari C, Taub D, Liao F, Farber J, Maheshwari S
J Exp Med. 1995; 182(1):155-62.
PMID: 7540647
PMC: 2192108.
DOI: 10.1084/jem.182.1.155.
Angiogenesis: role of calcium-mediated signal transduction.
Kohn E, Alessandro R, Spoonster J, Wersto R, Liotta L
Proc Natl Acad Sci U S A. 1995; 92(5):1307-11.
PMID: 7533291
PMC: 42508.
DOI: 10.1073/pnas.92.5.1307.